Literature DB >> 15477311

Molecular targeting: targeting angiogenesis in solid tumors.

J-C Soria1, J Fayette, J-P Armand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477311     DOI: 10.1093/annonc/mdh930

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Suppression of vascular endothelial growth factor via siRNA interference modulates the biological behavior of human nasopharyngeal carcinoma cells.

Authors:  Hai B Zhou; Yi F Yin; Yan Hu; Xin Li; Li Y Zou; Yong J Li; Yu Gu; Bao Q Ou; Juan Fu; Jun H Du; Gang Wu
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

2.  A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours.

Authors:  Aya El Helali; Ruth Plummer; Gordon C Jayson; Vicky M Coyle; Yvette Drew; Nerissa Mescallado; Noor Harris; Andrew R Clamp; Janine McCann; Helen Swaisland; Richard D Kennedy; Aaron N Cranston; Richard H Wilson
Journal:  Br J Cancer       Date:  2022-05-14       Impact factor: 9.075

3.  Targeted transport of 125I-labeled antibody to GFAP and AMVB1 in an experimental rat model of C6 glioma.

Authors:  Vladimir P Chekhonin; Vladimir P Baklaushev; Gaukhar M Yusubalieva; Olga I Gurina
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-04       Impact factor: 4.147

4.  Molecular imaging probes for diagnosis and therapy evaluation of breast cancer.

Authors:  Qingqing Meng; Zheng Li
Journal:  Int J Biomed Imaging       Date:  2013-02-26

5.  Non-Markovian Population Dynamics: Does it Help to Optimize the Chemotherapeutic Strategy?

Authors:  Dmitry A Kuznetsov; Sergey A Roumiantsev; Majid Fallahi; Nima Amirshahi; Andrey V Makarov; Karina S Kardashova
Journal:  Int J Biomed Sci       Date:  2010-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.